Ftse Mib
33.675,15
1,37%
DAX
18.254,18
1,03%
S&P 500
5.473,17
-0,25%
NASDAQ
17.721,59
-0,79%
Bitcoin
64.759,87
-0,09%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Mainz BioMed NV (MYNZ) Mainz BioMed NV (MYNZ) Notizie

Mainz BioMed NV

MYNZ
0,588
0,0128 (2,23%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 01:19:40
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/6/202414:01GLOBEMainz Biomed Presented Industry Leading Results of its..
31/5/202423:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/5/202423:01GLOBEMainz Biomed Reports Results of 2024 Annual General Meeting
28/5/202414:01GLOBEMainz Biomed to Present New Pooled Colorectal Cancer..
20/5/202414:01GLOBEMainz Biomed Awarded Poster of Distinction at Digestive..
10/5/202423:20EDGAR2Form D/A - Notice of Exempt Offering of Securities: [Amend]
07/5/202414:01GLOBEMainz Biomed to Present Results of Colorectal Cancer..
25/4/202415:29GLOBEMainz Biomed Reports Positive Topline Results from Pooled..
09/4/202414:01GLOBEMainz Biomed Reports Full Year 2023 Financial Results
19/3/202413:01GLOBEMainz Biomed Organizes HALLO DOC! Event to Highlight..
18/3/202413:01GLOBEMainz Biomed: Webinar on Early Detection of Colorectal..
12/3/202413:01GLOBEMainz Biomed Presents ColoAlert® at UDH Congress 2024:..
05/3/202414:01GLOBEMainz Biomed Partners with Trusted Health Advisors to..
27/2/202414:01GLOBEMainz Biomed to Showcase at the Gynecology Conference in..
22/2/202414:01GLOBEMainz Biomed Announces Distribution Partnership with..
21/2/202414:01GLOBEMainz Biomed Establishes Strategic Partnership with TomaLab..
06/2/202414:01GLOBEMainz Biomed Establishes Physician-Led Laboratory Expanding..
11/1/202414:01GLOBEMainz Biomed and TestDNA Drive CRC Innovation at the 10th..
09/1/202414:01GLOBEMainz Biomed Provides Year-End Corporate Review 2023
19/12/202314:01GLOBEMainz Biomed and Bantleon Partner to Elevate Corporate..
12/12/202314:01GLOBEMainz Biomed Showcases ColoAlert® at Two Prominent..
05/12/202315:01GLOBEMainz Biomed Reports Positive Topline Results from U.S...
29/11/202314:01GLOBEMainz Biomed’s Presentation at the 35th Annual Piper Sandler..
20/11/202314:01GLOBEMainz Biomed to Present at the 35th Annual Piper Sandler..
16/11/202314:01GLOBEMainz Biomed Reports Third Quarter 2023 Financial Results..
15/11/202315:01GLOBEMainz Biomed Announces Closing of $5.0 million Registered..
13/11/202315:00GLOBEMainz Biomed Announces Pricing of $5.0 million Registered..
09/11/202314:01GLOBEMainz Biomed Partners with Liquid Biosciences to Harness the..
07/11/202314:01GLOBEMainz Biomed to Showcase ColoAlert® at Leading Global..
31/10/202313:01GLOBEMainz Biomed Reports Success from Employee Colorectal Cancer..
26/10/202314:01GLOBEMainz Biomed Appoints Tarrin Khairi-Taraki as VP of..
18/10/202314:01GLOBEMainz Biomed Presents Groundbreaking Results of ColoFuture..
11/10/202314:01GLOBEMainz Biomed to Showcase ColoAlert® at UEG Week 2023 in..
05/10/202314:01GLOBEMainz Biomed to Attend the JonesTrading 2023 Healthcare..
04/10/202314:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
27/9/202314:01GLOBEMainz Biomed to Present Detailed Results of ColoFuture Study..
20/9/202309:01GLOBEMainz Biomed to Present at the Cantor Fitzgerald Global..
13/9/202309:01GLOBEMainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA..
05/9/202309:01GLOBEMainz Biomed Announces Strategic Partnership with Ärztliches..
29/8/202309:01GLOBEMainz Biomed to Present at the H.C. Wainwright Global..
22/8/202309:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
15/8/202312:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202309:01GLOBEMainz Biomed Announces Financial Half Year Results 2023 and..
01/8/202309:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
18/7/202309:01GLOBEMainz Biomed Announces Collaboration with Fugene Genetics in..
11/7/202322:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/6/202309:01GLOBEMainz Biomed Secures up to $50M in New Funding
28/6/202322:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/6/202322:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/6/202309:01GLOBEMainz Biomed to Attend ESMO World Congress on..
Apertura: 0,57 Min: 0,54 Max: 0,57
Chiusura: 0,5752

La tua Cronologia

NASDAQ
MYNZ
Mainz BioMed NV
HUOB
BOXUSDT
ContentBox Token
BIT
P12AB6
BNP PARIBAS ISSUANCE
BOV
KMBB34
Kimberly Cl DRN
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network